7 Needs context
Approximately 97.5% of United States healthcare spending goes to disease treatment, while only 2.5% is spent on disease prevention.
"we spend 97.5% of our healthcare dollars dealing with the treatment of diseases, much of which can be prevented. Only about 2.5% of healthcare expenditure in the United States goes to actual disease prevention." (said at 0:00:30)
The cited figure of ~2.5% for prevention and ~97.5% for treatment closely mirrors official National Health Expenditure Accounts (NHEA) data on government public health activity, which accounted for approximately 2.65% of US health expenditures in 2014 and was projected to reach ~2.4% by 2023. However, health economists note that this narrow figure reflects dedicated public health agency spending rather than total prevention. When clinical preventive services, screenings, and health promotion within clinical care are included, estimated spending on primary and secondary prevention ranges from approximately 5.1% to 8.6% of national health spending.
Fructose and alcohol are metabolized by the liver in virtually identical biochemical pathways after the initial glycolysis step.
"Well, turns out sugar, the molecule fructose, the sweet molecule in sugar, and alcohol are metabolized by the liver virtually identically... The big difference between sugar and alcohol is that for alcohol, the yeast does the first step of metabolism called glycolysis. For sugar, we do our own first step. But after that, the liver can't tell the difference as to where it came from." (said at 0:15:40)
The speaker is describing a well-known metabolic parallel popularized in the nutritional literature comparing the downstream hepatic fates of fructose and ethanol. Both bypass standard hepatic insulin-regulated checkpoints (such as phosphofructokinase for glucose), generating an unregulated influx of substrates (acetyl-CoA) that overwhelms mitochondrial capacity and promotes de novo lipogenesis, hepatic steatosis, and reactive oxygen species. However, describing their metabolism as "virtually identical" after an initial step is an oversimplification: ethanol is oxidized via alcohol dehydrogenase and aldehyde dehydrogenase into acetate and acetyl-CoA, whereas fructose is processed through fructokinase and aldolase B into three-carbon glycolytic intermediates (glyceraldehyde and dihydroxyacetone phosphate) before progressing to pyruvate, acetyl-CoA, gluconeogenesis, or glycogen synthesis.
- supports: Fructose: metabolic, hedonic, and societal parallels with ethanol. (Journal of the American Dietetic Association 2010) · cited 310x in the literature
"hepatic fructose metabolism is similar to ethanol, as they both serve as substrates for de novo lipogenesis, and in the process both promote hepatic insulin resistance, dyslipidemia, and hepatic steatosis." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Toward a unifying hypothesis of metabolic syndrome. (Pediatrics 2012) · cited 189x in the literature
"ethanol, and fructose. These 4 substrates (1) are not insulin regulated and (2) deliver metabolic intermediates to hepatic mitochondria without an appropriate "pop-off" mechanism for excess substrate, enhancing lipogenesis and ectopic adipose storage." (abstract, results, passage verified)
pubmedfull study (doi) - context: Fructose: it's "alcohol without the buzz". (Advances in nutrition (Bethesda, Md.) 2013) · cited 239x in the literature
"In the hypercaloric glycogen-replete state, intermediary metabolites from fructose metabolism overwhelm hepatic mitochondrial capacity, which promotes de novo lipogenesis and leads to hepatic insulin resistance, which drives chronic metabolic disease." (abstract, results, passage verified)
pubmedfull study (doi)
88% of adults in the United States have insulin resistance or metabolic dysfunction.
"and 88% of Americans have insulin resistance, have metabolic dysfunction because their liver is overwhelmed." (said at 0:19:15)
The 88% figure derives from a nationally representative cross-sectional study of NHANES 2009-2016 data (Araújo et al., 2019, n=8,721), which found that only 12.2% of US adults met all five criteria for optimal cardiometabolic health (optimal waist circumference, fasting glucose/HbA1c, blood pressure, triglycerides, and HDL cholesterol, without related medications). Consequently, 87.8% of adults had at least one suboptimal cardiometabolic risk factor. However, having a single non-optimal marker (such as prehypertension or elevated waist circumference) is not equivalent to having clinical insulin resistance, metabolic syndrome, or liver-driven metabolic dysfunction.
One out of every three new diabetes diagnoses in pediatric patients is type 2 diabetes.
"One out of every three new diabetes diagnoses is type 2 in kids" (said at 0:44:58)
Population surveillance from the SEARCH for Diabetes in Youth study shows that while type 1 diabetes remains the predominant form of pediatric diabetes, type 2 diabetes accounts for an increasing proportion of new diagnoses. Across the multi-center SEARCH registry (2002–2018), type 2 diabetes accounted for approximately 22.6% of new pediatric cases (5,293 of 23,462 total incident cases, or roughly 1 in 4.4). In recent years (2017–2018), type 2 diabetes incidence has risen significantly (annual incidence of 17.9 per 100,000 in youth aged 10–19 vs 22.2 per 100,000 for type 1 diabetes in youth aged 0–19), bringing the proportion of new diagnoses that are type 2 to roughly 1 in 3 to 1 in 4 across all youth, and even higher among adolescents aged 10–19 and racial/ethnic minority youth.
The reference range upper limit for alanine aminotransferase (ALT) in standard laboratory testing has shifted from 25 U/L in the 1970s up to 40 U/L today.
"I started in '76, and when I started, the upper limit for ALT was 25. Now today, if you pull out the lab slip and it just gives you the reference range, it tells you that the upper limit for ALT is 40." (said at 0:52:41)
Standard commercial laboratory reference intervals for alanine aminotransferase (ALT) have commonly reported upper limits of normal (ULN) around 40 U/L (and up to 45–55 U/L for men in many commercial assays). Epidemiological and clinical evaluations, such as the landmark study by Prati et al. (2002), demonstrated that traditional laboratory upper limits of 40 U/L for men and 30 U/L for women were established using reference populations that inadvertently included individuals with subclinical hepatic steatosis and occult viral hepatitis. When rigorously screened healthy cohorts are assessed, true physiological upper limits are lower (around 19–25 U/L in women and 30 U/L in men). While the speaker correctly notes that standard laboratory slips often report upper limits around 40 U/L despite true healthy thresholds being closer to 20–25 U/L, laboratory reference ranges vary widely by commercial assay and sex rather than reflecting a single uniform historical shift.
The average American consumes 7.5 servings of ultra-processed foods per day.
"And yet the average American is eating 7.5 servings of ultra-processed foods every day right now" (said at 1:09:32)
Dietary studies in large US prospective cohorts (such as the Nurses' Health Study and the Health Professionals Follow-up Study) and national surveys measure ultra-processed food (UPF) consumption ranging between approximately 5.7 and 7.5 servings per day (accounting for nearly 60% of daily caloric intake in the general US population). In these cohorts, 7.4 to 7.5 servings per day typically represents the upper intake categories (e.g., the highest quartile or top of the interquartile range), while the median intake is around 5.7 to 6.5 servings per day.
California requires physicians to complete 12 hours of continuing medical education (CME) in palliative care to maintain their medical license.
"In California, I had to take 12 hours of palliative care. As an endocrinologist, I had to take 12 hours of palliative care... they made me do that to keep my license, but no one says a damn thing about nutrition." (said at 1:03:32)
California law (under Business and Professions Code Section 2190.5, originally enacted via Assembly Bill 487 in 2001) mandates a one-time 12-hour continuing medical education (CME) requirement in pain management and the care of terminally ill and dying patients for licensed physicians and surgeons in California. While the speaker accurately states that physicians (including endocrinologists) practicing in California are required to complete 12 hours of CME covering palliative and end-of-life care / pain management to maintain licensure, it is a one-time requirement upon initial licensure or renewal rather than a recurring requirement for every license renewal cycle, and certain specialties (such as pathology and radiology) are exempt. Standard CME surveys across US states reflect widespread state-mandated topic-specific CME requirements for physician licensure (such as pain management and opioid prescribing), though these mandates vary by state and specialty relevancy.
No published study was located that directly addresses or verifies the speaker's comparative statement regarding nutrition education requirements relative to palliative care CME requirements in California.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.